Reza Received his PhD from the University of Groningen in the Netherlands in 2009. Following a few years of research in the area of proteins, nano and biomaterials at The University of Texas, Northwestern University and Radboud University Nijmegen, Reza joined the Leiden Academic Center for Drug Research in order to co-lead a European public-private partnership project (COMPACT) that addressed the current challenges with formulation and delivery of macromolecules. In the 4-year period of the COMPACT project, Reza’s research focused on characterization and understanding of protein aggregation in complex formulations as well as protein-material interactions. Reza then joined the Global Biologic Drug Product Development team of Sanofi and headed a formulation and process development laboratory in the Company’s R&D hub in Frankfurt, Germany. He developed early formulations and drug product manufacturing processes for several molecules in various modalities including antibodies and nanobodies. Reza is currently a faculty member of the Department of Pharmaceutical Sciences and Experimental Therapeutics.

Parham received his PhD in Chemical and Biochemical Engineering at the University of Iowa in 2023, where his research focused on developing non-invasive thermal treatments for controlling biofilm infections on medical implants. In November 2023, Parham joined Nejadnik Laboratory and the Center for Biocatalysis and Bioprocessing as a postdoctoral research scholar. In his current role, Parham is engaged in developing and optimizing experimental developability models for various proteins in addition to contributing to the creation of a database of biomanufacturing capabilities in the State of Iowa.

Siddhanth Hejmady received his Bachelor of Pharmacy from the University of Mumbai, India in 2017 and his Master of Pharmacy with specialisation in Pharmaceutics from the Birla Institute of Technology and Science, Pilani, India in 2020. Siddhanth worked as a Formulation Scientist developing complex generic products of small molecules in the Cipla R&D Center, Mumbai before joining the graduate program at the Department of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa. His current research work involves characterization of protein therapeutics and formulating biopharmaceuticals.

Hesham received his Bachelor of Pharmaceutical Sciences and his Master of Pharmaceutics and Drug Delivery from Minia University in 2016 and 2020 respectively. Hesham worked as a production pharmacist in a sterile manufacturing facility in Cairo, Egypt. After that, He shifted to academia and worked as a teaching associate in the pharmaceutics department at Deraya University where he conducted his research on enhancing the delivery of compounds from natural sources before joining the graduate program at the Department of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa. His current research work involves characterization and formulation of proteins and biosimilar products.

Eman received a Bachelor of Pharmaceutical Sciences and a Master of Pharmaceutics and Clinical Pharmacy from Minia University, Egypt in 2013 and 2018 respectively. After graduation in 2013, Eman joined the Department of Pharmaceutics and Clinical Pharmacy, Minia University as an associate lecturer. Eman has ample experiences working with cells including but not limited to cell culturing and freezing, cytotoxicity and viability assays, transfection and cell uptake studies. She also has performed translational research in the area of cancer nanomedicine while working as a visiting scholar at the Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, USA before joining the graduate program at the same department.

Isha is a graduate student in the Department of Pharmaceutical Sciences and Experimental Therapeutics at the University of Iowa. She earned her MSc in Pharmaceutics from University College London in 2022 and her Bachelor of Pharmacy from the University of Mumbai in 2020. As a Visiting Researcher at UCL, she worked on multiaxial electrospinning for insulin delivery, focusing on nanofiber formulation and characterization. She also has industry experience in regulatory affairs at Mankind Pharma and formulation development at Enem Nostrum Remedies. Her current research focuses on characterization of protein and cell therapeutics.

Yusra has joined the Liskin Swint-Kruse Lab at the University Of Kansas Medical Center as a postdoctoral researcher. Her research will focus on the evolution of protein functional variation to drive advances in personalized medicine.

Elham has joined the Salem Laboratory at the University of Iowa as a graduate student. Her research will focus on drug delivery and nanotechnology.

Sina has joined the Oliveros Laboratory at the State University of New York at Buffalo as a postdoctoral researcher. His research will focus on animal work, immunology, and flow cytometry, exploring the negative effects of chemotherapy treatment on learning/memory/mood.

Sanghati has joined Stira Pharmaceuticals in New Jersey, as a Senior Scientist. Her research will focus on peptide biotherapeutics, including analytical method development and identification, characterization, and quantification of nitrosamine-related impurities in biotherapeutic products.